Vascular Insights specializes in innovative medical technologies aimed at treating chronic venous disease, with a primary focus on the ClariVein® device. This device is designed for mechanochemical ablation, a minimally invasive procedure that combines mechanical and chemical methods to treat venous insufficiency. The ClariVein® device allows for the infusion of physician-specified agents directly into the peripheral vasculature, providing a targeted approach to managing conditions such as varicose veins. The technology is backed by multiple patents and has been the subject of various clinical studies, demonstrating its efficacy and safety in treating venous disorders.

The ClariVein® device is particularly noted for its ability to reduce intra-procedural pain and improve patient comfort compared to traditional methods like radiofrequency ablation. Clinical publications highlight its effectiveness in treating small saphenous vein insufficiency and other venous conditions, showcasing one-year results and long-term outcomes. The device's design and functionality aim to enhance the overall experience for both patients and physicians, making it a significant advancement in the field of vascular treatment.

United States

Vascular Insights manufactures and commercializes medical devices for the treatment of peripheral vascular disease.

Vascular Insights

Company Details